CDMO Opportunity United Biopharma offers integrated therapeutic mAb development and manufacturing services, presenting a direct cross-sell path for CRO/CDMO partnerships to support clients seeking end-to-end solutions from discovery to production.

Global Footprint With clinical development, R&D, and manufacturing centers in Taiwan and China and business presence in the USA, UBP can assist multinational biotechs seeking regional manufacturing capabilities or regional clinical execution with a single partner.

R&D Focus Approximately half of the workforce is in R&D and a large share holds master’s degrees or higher, signaling strong scientific and technical capability to support early-stage to mid-stage therapeutic mAb programs and complex project work.

Mid-Market Fit Annual revenue in the mid-range and team size of 11–50 positions UBP as a cost-competitive partner for small to mid-sized biotech firms aiming to scale manufacturing or accelerate development without engaging large-cap CDMOs.

Tech & Compliance Leveraging widely adopted tech stack (Google Workspace, analytics, and standard web servers) suggests scalable collaboration, digital project management, and data-driven performance tracking that can be highlighted in proposals to optimize workflow and analytics for client projects.